Software tools that power biomarker management, process simulation, and manufacturing coordination
Scale operations efficiently
Optimize manufacturing processes
Ensure trial compliance
Manage complex workflows
"We believe the future of cell and gene therapy lies in intelligent operations. Our mission is to provide the digital infrastructure that accelerates the journey from discovery to patient treatment."
Founder, Aseda Biotech
A newly identified blood biomarker, p-tau217, can predict Alzheimer's disease up to 15 years before symptoms emerge, offering hope for early intervention and personalized treatment.
Accelerating cell & gene therapy from bench to bedside.